Efficacy and Safety of Upadacitinib Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease: U-ENDURE Phase 3 Results

被引:0
作者
Panes, Julian [1 ]
Loftus, Edward, Jr. [2 ]
Lacerda, Ana [3 ]
Peyrin-Biroulet, Laurent [4 ]
D'Haens, Geert [5 ]
Panaccione, Remo [6 ]
Reinisch, Walter [7 ]
Louis, Edouard [8 ]
Chen, Minhu [9 ]
Nakase, Hiroshi [10 ]
Begun, Jakob [11 ]
Boland, Brigid [12 ]
Liu, Jianzhong [3 ]
Dubcenco, Elena [3 ]
Mohamed, Mohamed-Eslam [3 ]
Feng, Tian [3 ]
Colombel, Jean-Frederic [13 ]
机构
[1] Hosp Clin Barcelona, Barcelona, Spain
[2] Mayo Clin, Coll Med & Sci, Div Gastroenterol & Hepatol, Rochester, MN USA
[3] Abbvie Inc, Mettawa, IL USA
[4] Univ Lorraine, Nancy, France
[5] Univ Amsterdam, Med Ctr, Ctr Inflammatory Bowel Dis, Amsterdam, Netherlands
[6] Univ Calgary, Cumming Sch Med, Gastrointestinal Res, Inflammatory Bowel Dis Clin, Calgary, AB, Canada
[7] Med Univ Vienna, Vienna, Austria
[8] CHU Liege, Univ Hosp, Liege, Belgium
[9] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China
[10] Sapporo Med Univ, Sapporo, Hokkaido, Japan
[11] Mater Hosp Brisbane, Brisbane, Qld, Australia
[12] Univ Calif San Diego, San Diego, CA 92103 USA
[13] Icahn Sch Med Mt Sinai, Div Gastroenterol, New York, NY 10029 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
S37
引用
收藏
页码:S10 / S10
页数:1
相关论文
empty
未找到相关数据